Business Wire

BearingPoint client success story: JobRad Leasing ensures sustainable business growth through a successful financing transaction

11.12.2024 09:00:00 CET | Business Wire | Press release

Share

BearingPoint assisted JobRad Leasing GmbH in leveraging the Securitization as a Service solution to enhance its data management and reporting capabilities

As society increasingly values sustainability, bicycle mobility is becoming a popular choice for commuting. Another driver of this development is company bike leasing, invented by the Freiburg-based company JobRad. Similar to company car leasing, company bike leasing offers tax advantages that allow employees to save up to 40 percent in cash compared to buying a new bike. With its concept, the industry leader JobRad has so far brought more than 1.5 million people onto bikes. JobRad's central leasing company is the in-house JobRad Leasing GmbH. For refinancing strategies, the company has also been relying on asset-based refinancing for some time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211468345/en/

BearingPoint assisted JobRad Leasing GmbH in leveraging the Securitization as a Service solution to enhance its data management and reporting capabilities. (Graphic: Business Wire)

Securitization is key to this type of liquidity management, as it involves pooling financial assets such as loans, leases, or trade receivables and transforming them into a new financial investment product, known as asset-backed commercial paper (ABCP). However, creating a portfolio of eligible assets for ABCP involves managing extensive data from various sources, meeting reporting requirements, and adhering to eligibility criteria. As a result, for its first securitization transaction, the company sought to automate and efficiently develop the asset portfolio while maintaining the feasibility and high level of digitization that characterizes the entire JobRad Group.

Developing bespoke solutions for effective management of securitization transactions

Leveraging its Securitization as a Service solution,BearingPoint assisted JobRad Leasing GmbH in its first securitization transaction. The joint team conducted an interface workshop to identify the data requirements needed to meet market transparency standards. This laid the foundation for comprehensive documentation to pinpoint and evaluate the financial assets to be securitized. In the next step, relevant business logic was defined. Thereafter, BearingPoint configured the technical platform to incorporate JobRad Leasing’s data, business events, and the required types of reporting formats. During the development and testing phase, BearingPoint focused on aligning the reporting capabilities, while ensuring the accuracy and completeness of the data.

Detailed templates were then created for both the functionality and design of all corporate reports related to funding operations, ensuring that compliance standards were met, including reporting, documentation, and disclosure requirements. The project team integrated the securitization platform with the client's existing systems and workflows to enable a smooth transition and maximize operational efficiency. On an ongoing basis, BearingPoint will provide monthly reports throughout the transaction, using data from JobRad Leasing GmbH via the new interface to enable optimal and timely execution of the securitization transaction.

“Data is essential for JobRad to finance its sustainable solutions for eco-mobility in an efficient manner, particularly when it comes to securitization. We are very pleased that BearingPoint’s Securitization as a Service solution enables JobRad to meet the challenging capital market requirements for data quality and data transparency as it contributes to a stable funding, improved liquidity and efficient risk management,” said Donald Wachs, global Leader BearingPoint Products.

Simplifying the complexity of Asset-Based Funding

By using BearingPoint’s Securitization as a Service solution, JobRad Leasing GmbH has enhanced its data management capabilities and can handle effectively the complexities of its first securitization transaction. The highly automated processes have led to substantial improvements in time and resource efficiency. Additionally, the company now benefits from fast access to necessary reports and has shortened the report delivery times.

Moreover, the scalable operations and secure data enable JobRad Leasing GmbH to enhance its liquidity and effectively manage risk. With full visibility into its leasing transaction at all times, the company is able to address compliance and extensive investor transparency requirements, while also meeting the reporting standards set by the European Securities and Markets Authority (ESMA).

“Working with BearingPoint on our first securitization transaction has been a very positive experience for JobRad Leasing GmbH. With BearingPoint's solution, we were able to significantly simplify and streamline our processes and data management to meet our capital markets reporting requirements. As a result, we have been able to further broaden our refinancing base - bringing us one step closer to our goal of putting people on JobRad,” said Benjamin Kräutter, Team Leader Treasury at JobRad.

About JobRad

JobRad Leasing GmbH has been part of the JobRad Group since its market entry in 2019 and, as a bank-independent leasing company, works exclusively with JobRad employers.As one of two possible lessors, JobRad Leasing GmbH is a direct contractual partner of JobRad employers.

About BearingPoint

BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.

BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.

BearingPoint is a certified B Corporation, meeting high standards of social and environmental impact.

For more information, please visit:

Homepage: www.bearingpoint.com
Securitization as a Service: www.bearingpoint.services/securitization-as-a-service
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint

View source version on businesswire.com: https://www.businesswire.com/news/home/20241211468345/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye